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Table S1: Statistical summary for data presented in Fig. 1d. Values refer to mean ± SEM. NS, 
















       
Control Flox/+ 3 1055 2.51 ±	1.26 78.97 ±	2.48 10.85 ±	3.06 7.68 ±	0.67 
       
Control Flox/Flox 5 968 4.08 ±	1.07 78.94 ±	1.73 8.44 ±	1.33 7.59 ±	1.54 
       
p-value 
 








       
Cre 
Flox/+ 
4 815 3.73 ±	1.27 68.15 ±	3.39 9.23 ±	2.56 17.71 ±	1.48 
       
Cre 
Flox/Flox 
5 960 5.02 ±	1.07 49.03 ±	1.45 12.45 ±	1.73 30.85 ±	2.22 
       
p-value 
 











Table S2.  Enriched Gene Ontology terms associated with significant Casz1 interactors (via 
ShinyGO). 
 




Functional Category Proteins 
1.8807462742268e-13 5 16 NuRD complex  MTA1 GATAD2A GATAD2B MTA2 CHD4 
1.8807462742268e-13 5 16 CHD-type complex  MTA1 GATAD2A GATAD2B MTA2 CHD4 
1.14340386492051e-12 8 411 Nuclear chromatin  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 
1.41404754620054e-12 5 26 Nuclear transcriptional repressor 
complex  
MTA1 GATAD2A GATAD2B MTA2 CHD4 
1.32402638175635e-11 8 594 Chromatin  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 
3.1491552083781e-11 8 677 Nuclear chromosome part  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 
3.99720787629483e-11 8 711 Nuclear chromosome  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 
4.47966597363735e-11 5 57 Histone deacetylase complex  MTA1 GATAD2A GATAD2B MTA2 CHD4 
2.05052414406962e-10 5 79 Transcriptional repressor complex  MTA1 GATAD2A GATAD2B MTA2 CHD4 
2.05052414406962e-10 5 80 SWI/SNF superfamily-type complex  MTA1 GATAD2A GATAD2B MTA2 CHD4 
5.61253636773188e-10 8 1048 Chromosomal part  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 
5.61253636773188e-10 5 101 ATPase complex  MTA1 GATAD2A GATAD2B MTA2 CHD4 
1.04776986253554e-09 8 1156 Chromosome  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 
2.68769963443815e-07 9 3804 Nuclear lumen  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 CASZ1 
6.60279538008743e-07 9 4322 Membrane-enclosed lumen  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 CASZ1 
6.60279538008743e-07 9 4322 Organelle lumen  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 CASZ1 
6.60279538008743e-07 9 4288 Nuclear part  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 CASZ1 
6.60279538008743e-07 9 4321 Intracellular organelle lumen  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 CASZ1 
1.82248658251272e-06 4 219 Protein-DNA complex  HIST1H2BA CHD4 HIST1H1D HIST1H1B 
1.92523129289717e-05 3 120 Nucleosome  HIST1H2BA HIST1H1D HIST1H1B 
1.92523129289717e-05 8 4277 Non-membrane-bounded organelle  MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 
1.92523129289717e-05 8 4262 Intracellular non-membrane-
bounded organelle  
MTA1 GATAD2A GATAD2B HIST1H1D HIST1H1B MTA2 
HIST1H2BA CHD4 
2.08327137164028e-05 3 128 DNA packaging complex  HIST1H2BA HIST1H1D HIST1H1B 
2.30327002371074e-05 7 2900 Nucleoplasm  MTA1 GATAD2A GATAD2B MTA2 CHD4 CASZ1 
HIST1H2BA 
3.58746799781305e-05 5 1082 Nucleoplasm part  MTA1 GATAD2A GATAD2B MTA2 CHD4 
0.000110982809536114 5 1379 Catalytic complex  MTA1 GATAD2A GATAD2B MTA2 CHD4 
0.0119790202570926 2 391 Nuclear speck  GATAD2A GATAD2B 




Table S3: Statistical summary for data presented in Fig. 3h, i. Values refer to mean ± SEM. NS, 


















        
MSCV-EGFP 
+ vehicle 
7 1128 1707 3.43 ±	0.53 78.00 ±	1.67 10.29 ±	1.74 8.43 ±	0.84 
        
MSCV-EGFP 
+ TSA 
6 908 1503 3.17 ±	0.79 71.67 ±	0.88 14.50 ±	1.15 10.83 ±	1.08 
 
p-value vs.  
MSCV-EGFP 
veh 


























p-value vs.  
MSCV-EGFP 
veh 



























p-value vs.  
MSCV-EGFP 
veh 


























p-value vs.  
Casz1v2 veh 


























p-value vs.  
Casz1v2 veh 












Table S4: Statistical summary for data presented in Fig. 4. Values refer to mean ± SEM. NS, 




















3 865 4.99 ±	0.82 78.47 ±	0.96 10.75 ±	0.26 5.79 ±	0.39 
       
Hdac1 CRISPRi 3 621 14.74 ±	1.34 61.65 ±	5.18 1.97 ±	0.88 22.78 ±	4.59 




  0.0034 0.0331 0.0007 0.0180 
       
Control 5 2405 1.92 ±	0.93 88.01 ±	2.66 6.27 ±	0.99 4.53 ±	0.44 
(pCIG2) 
 
      
GATAD2A-335-
446 
4 2685 2.71 ±	0.68 75.80 ±	1.07 6.34 ±	0.63 14.80 ±	1.46 




  NS 0.0062 NS 0.0001 




Table S5: Statistical summary for data presented in Fig. 5c, d. Values refer to mean ± SEM. P-


















        
Control 
(pSiren) 
3 495 757 1.00 ±	0 90 ±	1.00 3.33 ±	0.33 5.33 ±	0.67 
        
shRing1a 4 800 1082 0.75 ±	0.25 79.50 ±	1.84 1.25 ±	0.25 19.00 ±	2.27 
p-value vs. 
control  








        
shRnf2-176 4 754 1067 0.50 ±	0.29 83.50 ±	1.32 2.50 ±	0.50 13.00 ±	0.71 
p-value vs. 
control  
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Table S6: Statistical summary for data presented in Fig. 5e, f. Values refer to mean ± SEM. P-
















13 4576 85.83 ±	2.01 6.66 ±	0.73 
     
Casz1v2 5 886 90.70 ±	1.13 3.58 ±	0.51 
p-value vs. 
control  




     
shCasz1 3 1633 79.43 ±	6.82 17.22 ±	3.11 
p-value vs. 
control 
  0.9575 0.0729 
     
shRing1a 4 405 65.39 ±	5.12 27.92 ±	3.15 
p-value vs. 
control 
  0.0043 < 0.0001 
     
shRnf2-176 4 625 78.56 ±	1.67 19.91 ±	1.90 
p-value vs. 
control 
  0.8522 < 0.0001 
     
shRnf2-389 5 1500 76.81 ±	3.99 15.94 ±	3.04 
p-value vs. 
control 
  0.5452 0.0427 
     
shRnf2-389 + 
HsRnf2 
4 447 82.27 ±	1.48 10.01 ±	1.30 
p-value vs. 
control 
  0.1987 0.9785 
     
shRing1 + 
Casz1v2 
4 279 55.24 ±	4.54 35.51 ±	6.09 
p-value vs. 
control 








     
shRnf2-176 + 
Casz1v2 
6 465 83.80 ±	2.01 14.44 ±	1.93 
p-value vs. 
control 
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Table S7: Oligonucleotide sequences. 
 
Name Purpose Sequence 
CasSALacZ-F genotyping 5’-GAGGGAGGTTGGCAAGAGGTGA-3’ 
CasSALacZ-R genotyping 5’-GGACCTGGTTGTCATGGAGGAGAA-3’ 
CasFlox-R genotyping  5’-CTGGCCGATGGCTTTTCAGTACA-3’ 
Rosa-26 (1) genotyping 5’-AAAGTCGCTCTGAGTTGTTAT-3’ 
Rosa-26 (2) genotyping 5’-GCGAAGAGTTTGTCCTCAACC-3’ 
Rosa-26 (3) genotyping 5’-GGAGCGGGAGAAATGGATATG-3’ 
Hdac1 TSS F CRISPRi 5’-CACCGCGGCTATAGGTGATCCCGGGGG-3’ 
Hdac1 TSS R CRISPRi 5’- AAACCCCCCGGGATCACCTATAGCCGC-3’ 
Hdac2 TSS F CRISPRi 5’-CACCAGTCCGGAGGTGCGCACAAGCGG-3’ 













shRing1-F:  shRNA 5'_gatccGTGCACAGAATGCCAGCAAATTCAAGAGATTTGCTGGCATTCTGT
GCATTTTTTgatatcg_3' 













Table S8: Primary antibodies and dilutions. 
  
Antigen Species Dilution Supplier Application 
Casz1 Rabbit 1:1000 Seth Blackshaw Lab 
C5-2 
IP/Western 
Casz1 Guinea pig 1:200 Johan Ericsson Lab 
Cst95 
IHC 
Cbx1 Rat 1:500 Abcam ab10811 IHC 
Ccnd3 Mouse 1:100 Santa Cruz D-7 IHC 
Chd4 Rabbit 1:1000 Abcam ab72418 IP/Western 
Chd4 Rabbit 1:200 Active Motif  39289 IHC 
Flag Rabbit 1:1000 Cell Signaling 2368P Western 
GFP Rabbit 1:1000 Molecular Probes 
A11122 
IP/IHC 
GFP Mouse 1:1000 DSHB  GFP-G1 IHC 
H2AK119ub1 Rabbit 1:1000 Cell Signaling 8240 Western 
H3K9me3 H3K9me3 1:200 Diagenode 
C15410056 
IHC 






Hdac2 Rabbit 1:200 
1:1000 
Bethyl A300-705 IHC 
Western 
Mbd3 Rabbit 1:1000 Bethyl  A302-529 
 
Western 
Pax6 Mouse 1:10 DSHB Pax6 IHC 
 
Rnf2 Mouse 1:1000 MBL D139-3 Western 
Sox2 Goat 1:500 R&D Systems 
AF2018 
IHC 






Fig. S1. Casz1 and NuRD complex proteins localize to heterochromatin in retinal 
progenitors. (a) Casz1 immunohistochemistry on E17.5 Casz1Flox/Flox; α–Pax6::Cre; R26-Stop-
EYFP (cKO) retinal sections in mosaic regions containing recombinant (ie. EYFP+) and 
unrecombined (EYFP-negative) RPCs. Note that Casz1 protein staining disappears in the 
EYFP+ cells (arrowheads). Casz1 is localized diffusely throughout the nucleus, but is enriched 
on the outer margins of chromocenters (red circles). (b, c) Casz1 protein colocalizes with the 
heterochromatic marks H3K9me3 (b) or Cbx1 (c) on the margins of chromocenters (red circles) 
in E18.5 retinal progenitors. (d, e) Double-staining for Casz1 and Chd4 (d) or Hdac2 (e) on P0 





Fig. S2. Hdac1 CRISPRi validation. (a, b) Murine P19 embryonal carcinoma cells were 
transfected with GFP (pCIG2) and dCas9-KRAB-MeCP2, with or without guide constructs 
targeting the transcription start sites of Hdac1 or Hdac2 as indicated. (a) Cells were harvested 
and subjected to western blotting for Hdac1, GFP (reporting transfection efficiency), or ß-actin 
(loading control). (b) Densitometry was performed on Hdac1 protein levels normalized against 
ß-actin levels. * p = 0.0171, n=5. (c-f) In vivo electroporation of P0 retinas with Hdac1 CRISPRi. 
Retinas were harvested at P21 and visualized for GFP epifluorescence, Hdac1 
immunohistochemistry (red) and Hoechst (blue) using Airyscan confocal microscopy. (d, f) 
GFP+ transfected cells or randomly-selected neighboring cells were analyzed for Hdac1 levels 
via densitometry. In both the ONL (d, e) and INL (f, g), transfected cells exhibited reduced 
Hdac1 levels in comparison to neighbors, although overall Hdac1 levels were lower in the ONL 





Fig. S3. Casz1 requires polycomb to control retinal progenitor output. (a-d) 
Representative examples of Casz1 and polycomb loss-of-function transfections. P0 retinas 
were electroporated with the indicated construct combinations, and harvested after 14 days in 
vitro. Explants were stained for Ccnd3, which marks Müller glia (circles). (a) Control (pCIG2); 
(b) Casz1v2; (c) shRnf2-176; (d) Casz1v2 + shRnf2-176. Dashed line indicates the boundary 




















Supplemental datafile 1. Spreadsheet of RNA-seq data presented in Fig. 1 (Excel file). 
 
Supplemental datafile 2. Spreadsheet of BioID experimental results (Excel file). 
 
 
 
 
 
 
